Organizations Filed Purposes:
The purpose of Tisch Multiple Sclerosis Research Center of NY, Inc. is to conduct medical research directed toward finding the cause and eventual cure for multiple sclerosis.
TISCH MS RESEARCH CENTER OF NEW YORKS (TISCH MSRCNY) MISSION IS TO CONDUCT MEDICAL RESEARCH DIRECTED TOWARD DISCOVERING THE CAUSE OF AND EVENTUAL CURE FOR MULTIPLE SCLEROSIS. IN 2019, 45 STUDY SUBJECTS WERE RECRUITED TO PARTICIPATE IN THE PHASE II CLINICAL TRIAL OF STEM CELLS IN MS, AND 25 SUBJECTS BEGAN THE TREATMENT PHASE OF THE STUDY. IN ADDITION, THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND INSTITUTIONAL REVIEW BOARD (IRB) GRANTED APPROVAL TO BEGIN ADMINISTERING STEM CELL TREATMENT TO MS PATIENTS UNDER A COMPASSIONATE USE (EXPANDED ACCESS) PROTOCOL. OTHER PROGRAM ACCOMPLISHMENTS INCLUDE THE FOLLOWING: IN JANUARY 2019, SCIENTIST DR. NICOLAS DAVIAUD, WAS RECRUITED TO START AN ORGANOID RESEARCH PROGRAM AT TISCH MSRCNY. DRS JAMES STARK AND SAUD SADIQ, ALONG WITH CLINICAL RESEARCH ASSISTANTS AT TISCH MSRCNY, PUBLISHED A PAPER ON THE LONG TERM EFFECTS OF INTRATHECAL METHOTREXATE IN PROGRESSIVE MS PATIENTS. TISCH MSRCNY RESEARCHERS WERE INVITED TO PRESENT RESEARCH ABSTRACTS AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING, INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH, AND THE SOCIETY FOR NEUROSCIENCE ANNUAL MEETING, ALL HELD IN 2019. IN 2019, TISCH MSRCNY BEGAN CONSTRUCTION ON A NEW FACILITY, THE EXPERIMENTAL RESEARCH CENTER, AN EXPANSION OF THE EXISTING LABORATORIES. THIS PROJECT IS EXPECTED TO BE COMPLETED BY THE END OF 2020.
AS AN ACADEMIC FACILITY, THE TISCH MS RESEARCH CENTER PROVIDES EDUCATIONAL AND TRAINING RESOURCES FOR MS RESEARCHERS AND MEDICAL PROFESSIONALS. ONE OF THE MOST IMPORTANT GOALS OF TISCH MSRCNY IS TO PROVIDE RESEARCH OPPORTUNITIES FOR YOUNG SCIENCE GRADUATES THAT ENABLE THEM TO BECOME CAREER SCIENTISTS AND DOCTORS. SINCE ITS INCEPTION, THEY HAVE TRAINED OVER 100 COLLEGE GRADUATES AS RESEARCH ASSISTANTS (RAS) FOR 2-YEAR ROTATIONS. IN 2019, ALL SECOND YEAR RESEARCH ASSISTANTS, UNDER THE GUIDANCE OF TISCH MSRCNY PRINCIPAL INVESTIGATORS, MATRICULATED TO TOP MEDICAL SCHOOLS AND GRADUATE PROGRAMS. FELLOWSHIPS IN MS RESEARCH ARE ALSO OFFERED TO PHYSICIANS AND SCIENTISTS INTERESTED IN ENTERING OR EXPANDING THEIR WORK IN THIS FIELD. THE CENTER PUBLISHED A PAPER IN EBIOMEDICINE, AN ONLINE JOURNAL. IN OCTOBER 2019, THE TISCH MS RESEARCH CENTER OF NEW YORK HOSTED THE LARGEST ANNUAL MS PATIENT EDUCATION SYMPOSIUM IN THE UNITED STATES WITH APPROXIMATELY 450 ATTENDEES. WEEKLY GRAND ROUNDS AND JOURNAL CLUB MEETINGS TAKE PLACE IN OUR CONFERENCE ROOM TO DISCUSS THE LATEST ADVANCEMENTS IN MS RESEARCH AND HOW IT APPLIES TO OUR CURRENT INVESTIGATIONS. THESE RESEARCH INITIATIVES INCLUDE: TO BETTER UNDERSTAND AND TREAT COORDINATION AND BALANCE DIFFICULTIES IN PATIENTS WITH MS. TO CREATE AN EXPERIMENTAL MODEL OF PROGRESSIVE MS THAT WILL ENABLE US TO BETTER UNDERSTAND AND TREAT PATIENTS WITH SECONDARY PROGRESSIVE MS (SPMS) AND PRIMARY PROGRESSIVE MS (PPMS). FINALLY, AND PERHAPS MOST IMPORTANTLY, WE NEED TO IDENTIFY THE INITIAL TRIGGER(S) THAT CAUSE MS.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
Name | Title | Hours Per Week | Total Salary |
Violaine Harris | Senior Research Scientist | 40 | $193,265 |
Amanda B Oppenheimer | Chief Financial Officer | 40 | $143,698 |
Lisa Mandel | Director of Development | 40 | $139,542 |
Jerry Lin | Senior Staff Associate | 40 | $123,586 |
Cliff Eisler | Treasurer | 5 | $0 |
Thomas R Mayer | Director | 2 | $0 |
Musa Mayer | Director | 2 | $0 |
Alla Weisberg | Director | 2 | $0 |
Stanley Trotman | Director | 2 | $0 |
Daniel Tisch | Director | 2 | $0 |
Bonnie Tisch | Director | 2 | $0 |
Richard Schwartz | Director | 2 | $0 |
Greta Rubin Schwartz | Director | 2 | $0 |
Saud A Sadiq Md | Director/Chief Research Scientist | 40 | $0 |
Jeanette Rosenblum | Director | 2 | $0 |
David Rosenblum | Director | 2 | $0 |
Sharyl Reisman | Secretary | 5 | $0 |
Philip J Purcell | Director | 2 | $0 |
James C Pigott | Director | 2 | $0 |
Gaye T Pigott | Director | 2 | $0 |
Philip Peller | Director | 5 | $0 |
Monika Parekh | Director | 2 | $0 |
Deven Parekh | Director | 2 | $0 |
Stephen Meyers | Director | 2 | $0 |
Elizabeth Maslow Montesano | Director | 2 | $0 |
James Mariani | Director | 2 | $0 |
Bernadette Mariani | Director | 2 | $0 |
Paul Lattanzio | Director | 2 | $0 |
Peter J Green | Director | 2 | $0 |
David A Goldberg | Director | 2 | $0 |
Bradley H Freidrich | Director | 2 | $0 |
Bonnie Eisler | Director | 2 | $0 |
Cynthia Brodsky | Director | 2 | $0 |
Enke Bashllari Phd | Director | 2 | $0 |
David G Greenstein | Director | 5 | $0 |
Lee J Seidler | Chairman Emeritus | 5 | $0 |
Philip Weisberg | Chairman | 15 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202042659349300774_public.xml